Dasatinib, a drug that often is used to treat certain types of leukemia, may have antidiabetic effects comparable to medications used to treat diabetes, and with more research may become a novel therapy for diabetic patients, according to new research published in Mayo Clinic Proceedings. Dasatinib is a tyrosine kinase inhibitor used to treat tumors […]
Read More.. Retrospective study finds that cancer drug also lowers blood glucose